Brain atrophy and strategic lesion location increases risk of parkinsonism in cerebral small vessel disease.
暂无分享,去创建一个
D. Norris | B. Platel | E. V. van Dijk | R. Esselink | Mohsen Ghafoorian | A. Tuladhar | H. M. van der Holst | E. V. van Leijsen | M. Bergkamp | I. W. M. van Uden | F. D. Leeuw | Ingeborg W M van Uden | Esther M C van Leijsen
[1] Aad van der Lugt,et al. Prevalence and Risk Factors of Cerebral Microbleeds: An Update of the Rotterdam Scan Study , 2010, Stroke.
[2] R. Righart,et al. Acute infarcts cause focal thinning in remote cortex via degeneration of connecting fiber tracts , 2015, Neurology.
[3] K. D. de Laat,et al. Cerebral White Matter Lesions and Lacunar Infarcts Contribute to the Presence of Mild Parkinsonian Signs , 2012, Stroke.
[4] A. Alavi,et al. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. , 1987, AJR. American journal of roentgenology.
[5] Gert Jan Lammers,et al. Assessment of sleep and sleepiness in Parkinson disease. , 2003, Sleep.
[6] R. Barker,et al. Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease? , 2016, Movement disorders : official journal of the Movement Disorder Society.
[7] K. Jellinger. Prevalence of cerebrovascular lesions in Parkinson's disease. A postmortem study , 2003, Acta Neuropathologica.
[8] R. Gray. A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .
[9] D. Norris,et al. Cerebral small vessel disease and incident parkinsonism , 2015, Neurology.
[10] N. Xiong,et al. Immune Reconstitution Inflammatory Syndrome Secondary to Autoimmune Hemolytic Anemia and Cryptococcal Meningitis , 2019, Front. Neurol..
[11] I. McKeith,et al. SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders , 2003, Movement disorders : official journal of the Movement Disorder Society.
[12] Y. Sohn,et al. Topography of cortical thinning associated with white matter hyperintensities in Parkinson's disease. , 2015, Parkinsonism & related disorders.
[13] Charles DeCarli,et al. White matter hyperintensities and cognition: Testing the reserve hypothesis , 2011, Neurobiology of Aging.
[14] J. Kaye,et al. Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline , 2008, Neurology.
[15] Ivan Rektor,et al. An updated diagnostic approach to subtype definition of vascular parkinsonism - Recommendations from an expert working group. , 2017, Parkinsonism & related disorders.
[16] K. Kitagawa,et al. Association between cerebral small vessel diseases and mild parkinsonian signs in the elderly with vascular risk factors. , 2016, Parkinsonism & related disorders.
[17] L. Radloff. The CES-D Scale , 1977 .
[18] H. Markus,et al. Longitudinal patterns of leukoaraiosis and brain atrophy in symptomatic small vessel disease , 2016, Brain : a journal of neurology.
[19] D. Norris,et al. Causes and consequences of cerebral small vessel disease. The RUN DMC study: a prospective cohort study. Study rationale and protocol , 2011, BMC neurology.
[20] Yung-Yee Chang,et al. The relationship of leukoaraiosis and the clinical severity of vascular Parkinsonism , 2014, Journal of the Neurological Sciences.
[21] A. Hofman,et al. Incidental findings on brain MRI in the general population. , 2007, The New England journal of medicine.
[22] Amos D. Korczyn,et al. Vascular parkinsonism—characteristics, pathogenesis and treatment , 2015, Nature Reviews Neurology.
[23] P. Satz. Brain reserve capacity on symptom onset after brain injury: A formulation and review of evidence for threshold theory. , 1993 .
[24] Andrew J Lees,et al. Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis , 2004, Movement disorders : official journal of the Movement Disorder Society.
[25] Nicolaas I. Bohnen,et al. White matter lesions in Parkinson disease , 2011, Nature Reviews Neurology.
[26] F. Aversa,et al. Competing risk analysis using R: an easy guide for clinicians , 2007, Bone Marrow Transplantation.
[27] Nico Karssemeijer,et al. Automated detection of white matter hyperintensities of all sizes in cerebral small vessel disease. , 2016, Medical physics.
[28] A. Stefani,et al. The relationship between cerebral vascular disease and parkinsonism: The VADO study. , 2012, Parkinsonism & related disorders.
[29] Nick C Fox,et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.
[30] R. Albin,et al. Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease. , 2011, Brain : a journal of neurology.
[31] Y. Stern. What is cognitive reserve? Theory and research application of the reserve concept , 2002, Journal of the International Neuropsychological Society.